Savara to present IMPALA-2 trial data at ERS Congress in Barcelona

August 24, 2026 4:05 PM

Savara Inc. (Nasdaq: SVRA) announced that one oral presentation and two poster presentations on data from its Phase 3 IMPALA-2 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found